The COVID-19 Pandemic and Coronary Angiography for ST-Elevation Myocardial Infarction, Use of Mechanical Support, and Mechanical Complications in Canada: A Canadian Association of Interventional Cardiology National Survey.

Autor:	Rinfret S; Division of Cardiology, McGill University Health Centre, McGill University, Montreal, Quebec, Canada., Jahan I; Department of Medicine and Biostatistics, McGill University Health Centre, McGill University, Montreal, Quebec, Canada., McKenzie K; Canadian Association of Interventional Cardiology, Ottawa, Ontario, Canada., Dendukuri N; Department of Medicine and Biostatistics, McGill University Health Centre, McGill University, Montreal, Quebec, Canada., Bainey KR; Division of Cardiology, Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada., Mansour S; Division of Cardiology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.; Division of Cardiology, Hôpital de la Cité-de-la-Santé, Laval, Quebec, Canada., Natarajan M; Division of Cardiology, Hamilton Health Sciences Centre, Hamilton, Ontario, Canada., Ybarra LF; Division of Cardiology, London Health Sciences Centre, London, Ontario, Canada., Chong AY; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada., Bérubé S; Division of Cardiology, CIUSSS de l'Estrie-CHUS, Sherbrooke, Quebec, Canada., Breton R; Division of Cardiology, CIUSSS Saguenay Lac Saint Jean, Saguenay, Quebec, Canada., Curtis MJ; Division of Cardiology, Foothills Medical Centre, Calgary, Alberta, Canada., Rodés-Cabau J; Multidisciplinary Department of Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec-Hôpital Laval, Quebec City, Quebec, Canada., Shy Shoaib A; Division of Cardiology, William Osler Health System, Brampton, Ontario, Canada., Bagherli A; Division of Cardiology, Windsor Regional Hospital, Windsor, Ontario, Canada., Ball W; Division of Cardiology, Peterborough Regional Health Centre, Peterborough, Ontario, Canada., Barolet A; Division of Cardiology, University Health Network-Toronto General Hospital, Toronto, Ontario, Canada., Beydoun HK; Division of Cardiology, QEII Health Sciences Centre, Halifax, Nova Scotia, Canada., Brass N; Division of Cardiology, CK Hui Heart Centre/Royal Alexandra Hospital, Edmonton, Alberta, Canada., Chan AW; Division of Cardiology, Royal Columbian Hospital, New Westminster, British Columbia, Canada., Colizza F; Division of Cardiology, Centre Hospitalier Pierre-Boucher, Longueuil, Quebec, Canada., Constance C; Division of Cardiology, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada., Fam NP; Division of Cardiology, St. Michael's Hospital, Montreal, Quebec, Canada., Gobeil F; Division of Cardiology, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada., Haghighat T; Division of Cardiology, CISSSO-Hull Hospital, Gatineau, Quebec, Canada., Hodge S; Division of Cardiology, Kelowna General Hospital, Kelowna, British Columbia, Canada., Joyal D; Division of Cardiology, Jewish General Hospital, Montreal, Quebec, Canada., Kim HH; Division of Cardiology, St-Mary's Regional Cardiac Care Centre, Kitchener-Waterloo, Ontario, Canada., Lutchmedial S; Division of Cardiology, Saint John Regional Hospital, Saint John, New Brunswick, Canada., MacDougall A; Division of Cardiology, Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, Canada., Malik P; Division of Cardiology, Kingston General Hospital, Kingston, Ontario, Canada., Miner S; Division of Cardiology, Southlake Regional Health Centre, Newmarket, Ontario, Canada., Minhas K; Division of Cardiology, St. Boniface General Hospital, Winnipeg, Manitoba, Canada., Orvold J; Division of Cardiology, Royal University Hospital, Saskatoon, Saskatchewan, Canada., Palisaitis D; Division of Cardiology, Sacred Heart Hospital, Montreal, Quebec, Canada., Parfrey B; Division of Cardiology, Health Sciences Centre, St-John's, Newfoundland, Canada., Potvin JM; Division of Cardiology, CHU de Québec, Quebec City, Quebec, Canada., Puley G; Division of Cardiology, Trillium Health Centre, Mississauga, Ontario, Canada., Radhakrishnan S; Division of Cardiology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Spaziano M; Division of Cardiology, McGill University Health Centre, McGill University, Montreal, Quebec, Canada., Tanguay JF; Division of Cardiology, Cardiology Institute of Montreal, Montreal, Quebec, Canada., Vijayaraghaban R; Division of Cardiology, Rouge Valley Centenary, Scarborough, Ontario, Canada., Webb JG; Division of Cardiology, St. Paul's Hospital, Vancouver, British Columbia, Canada., Zimmermann RH; Division of Cardiology, Regina General Hospital, Regina, Saskatchewan, Canada., Wood DA; Division of Cardiology, Vancouver General Hospital, Vancouver, British Columbia, Canada., Brophy JM; Division of Cardiology, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
Jazyk:	angličtina
Zdroj:	CJC open [CJC Open] 2021 Sep; Vol. 3 (9), pp. 1125-1131. Date of Electronic Publication: 2021 May 12.
DOI:	10.1016/j.cjco.2021.04.017
Abstrakt:	Background: As a result of the COVID-19 pandemic first wave, reductions in ST-elevation myocardial infarction (STEMI) invasive care, ranging from 23% to 76%, have been reported from various countries. Whether this change had any impact on coronary angiography (CA) volume or on mechanical support device use for STEMI and post-STEMI mechanical complications in Canada is unknown. Methods: We administered a Canada-wide survey to all cardiac catheterization laboratory directors, seeking the volume of CA use for STEMI performed during the period from March 1 2020 to May 31, 2020 (pandemic period), and during 2 control periods (March 1, 2019 to May 31, 2019 and March 1, 2018 to May 31, 2018). The number of left ventricular support devices used, as well as the number of ventricular septal defects and papillary muscle rupture cases diagnosed, was also recorded. We also assessed whether the number of COVID-19 cases recorded in each province was associated with STEMI-related CA volume. Results: A total of 41 of 42 Canadian catheterization laboratories (98%) provided data. There was a modest but statistically significant 16% reduction (incidence rate ratio [IRR] 0.84; 95% confidence interval 0.80-0.87) in CA for STEMI during the first wave of the pandemic, compared to control periods. IRR was not associated with provincial COVID-19 caseload. We observed a 26% reduction (IRR 0.74; 95% confidence interval 0.61-0.89) in the use of intra-aortic balloon pump use for STEMI. Use of an Impella pump and mechanical complications from STEMI were exceedingly rare. Conclusions: We observed a modest 16% decrease in use of CA for STEMI during the pandemic first wave in Canada, lower than the level reported in other countries. Provincial COVID-19 caseload did not influence this reduction. (© 2021 Published by Elsevier Inc. on behalf of Canadian Cardiovascular Society.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu